KCNN4 | Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters Voltage-gated ion channels
| ![](/images/59622/ihc_selected_60x60.jpg) | ![](/images/53841/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/53841/133784_B_2_4_rna_selected_60x60.jpg) | Tissue enhanced |
KCNQ1 | Potassium voltage-gated channel, KQT-like subfamily, member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48553/123855_A_1_2_rna_selected_60x60.jpg) | Tissue enhanced |
KCNQ2 | Potassium voltage-gated channel, KQT-like subfamily, member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/57112/ihc_selected_60x60.jpg) | ![](/images/57112/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/57112/140451_B_8_1_rna_selected_60x60.jpg) | Group enriched |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | | ![](/images/14341/39080_B_8_5_rna_selected_60x60.jpg) | Group enriched |
RYR1 | Ryanodine receptor 1 (skeletal) | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | ![](/images/56416/1183_H4_2_selected_60x60.jpg) | ![](/images/56416/ihc_cell_selected_60x60.jpg) | ![](/images/56416/140329_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
SCN11A | Sodium channel, voltage-gated, type XI, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/36746/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/36746/78169_A_2_3_rna_selected_60x60.jpg) | Tissue enhanced |
SCN2A | Sodium channel, voltage-gated, type II, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22567/52670_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
SCN4A | Sodium channel, voltage-gated, type IV, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/53992/ihc_selected_60x60.jpg) | ![](/images/53992/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/53992/121967_A_1_4_rna_selected_60x60.jpg) | Group enriched |
SCN4B | Sodium channel, voltage-gated, type IV, beta subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| ![](/images/17293/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17293/39892_B_8_2_rna_selected_60x60.jpg) | Mixed |
SCN9A | Sodium channel, voltage-gated, type IX, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/13679/ihc_selected_60x60.jpg) | ![](/images/61843/1332_D6_4_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/13679/30464_B_9_2_rna_selected_60x60.jpg) | Mixed |
SCNN1A | Sodium channel, non-voltage-gated 1 alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| ![](/images/12939/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/12939/30030_B_8_6_rna_selected_60x60.jpg) | Mixed |
SCNN1B | Sodium channel, non-voltage-gated 1, beta subunit | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| ![](/images/15612/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15612/35987_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
SCTR | Secretin receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| ![](/images/7269/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/7269/147549_B_5_2_rna_selected_60x60.jpg) | Group enriched |
SLC12A1 | Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | ![](/images/18107/if_selected_60x60.jpg) | ![](/images/14967/ihc_cell_selected_60x60.jpg) | ![](/images/14967/33483_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
SLC12A2 | Solute carrier family 12 (sodium/potassium/chloride transporter), member 2 | FDA approved drug targets Predicted membrane proteins Transporters
| ![](/images/20130/47733_A_3_3_selected_60x60.jpg) | ![](/images/63697/1132_A7_3_selected_60x60.jpg) | ![](/images/20130/ihc_cell_selected_60x60.jpg) | ![](/images/20130/47732_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
SLC12A3 | Solute carrier family 12 (sodium/chloride transporter), member 3 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28748/141823_A_3_6_rna_selected_60x60.jpg) | Tissue enriched |
SLC12A4 | Solute carrier family 12 (potassium/chloride transporter), member 4 | FDA approved drug targets Predicted membrane proteins Transporters
| ![](/images/41138/ihc_selected_60x60.jpg) | ![](/images/41138/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/41138/86919_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
SLC12A5 | Solute carrier family 12 (potassium/chloride transporter), member 5 | FDA approved drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/72058/159045_A_2_1_rna_selected_60x60.jpg) | Tissue enriched |
SLC18A2 | Solute carrier family 18 (vesicular monoamine transporter), member 2 | FDA approved drug targets Predicted membrane proteins Transporters
| ![](/images/16856/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16856/39438_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
SLC22A11 | Solute carrier family 22 (organic anion/urate transporter), member 11 | FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| ![](/images/26076/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/26076/56673_B_8_7_rna_selected_60x60.jpg) | Group enriched |
SLC22A8 | Solute carrier family 22 (organic anion transporter), member 8 | FDA approved drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/44174/ihc_cell_selected_60x60.jpg) | ![](/images/44174/147449_A_7_6_rna_selected_60x60.jpg) | Tissue enriched |
SLC25A4 | Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 | Disease related genes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins Transporters
| ![](/images/60665/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60665/144562_A_2_1_rna_selected_60x60.jpg) | Group enriched |
SLC25A5 | Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 | FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted membrane proteins Transporters
| ![](/images/60665/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60665/144564_B_8_7_rna_selected_60x60.jpg) | Expressed in all |
SLC25A6 | Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 | FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted membrane proteins Transporters
| ![](/images/60665/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60665/144562_A_2_1_rna_selected_60x60.jpg) | Expressed in all |
SLC52A2 | Solute carrier family 52 (riboflavin transporter), member 2 | Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| ![](/images/63036/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/63036/143854_B_8_7_rna_selected_60x60.jpg) | Expressed in all |
SLC5A2 | Solute carrier family 5 (sodium/glucose cotransporter), member 2 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/41603/ihc_cell_selected_60x60.jpg) | ![](/images/41603/148722_B_8_3_rna_selected_60x60.jpg) | Tissue enriched |
SLC6A1 | Solute carrier family 6 (neurotransmitter transporter), member 1 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | ![](/images/13341/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/22293/56979_B_8_5_rna_selected_60x60.jpg) | Group enriched |
SLC6A3 | Solute carrier family 6 (neurotransmitter transporter), member 3 | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| ![](/images/13602/ihc_selected_60x60.jpg) | ![](/images/13602/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/13602/30986_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
SLC6A4 | Solute carrier family 6 (neurotransmitter transporter), member 4 | FDA approved drug targets Predicted membrane proteins Transporters
| ![](/images/mb_image_stack/54723/98/B-07_60x60_470.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
SLC8A1 | Solute carrier family 8 (sodium/calcium exchanger), member 1 | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| ![](/images/22694/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22694/49717_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
SLCO2B1 | Solute carrier organic anion transporter family, member 2B1 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| ![](/images/20659/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/20659/46870_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
SNAP25 | Synaptosomal-associated protein, 25kDa | FDA approved drug targets Predicted intracellular proteins Transporters
| | ![](/images/1830/if_selected_60x60.jpg) | ![](/images/1830/ihc_cell_selected_60x60.jpg) | ![](/images/1830/7269_B_2_2_rna_selected_60x60.jpg) | Tissue enriched |
TRPA1 | Transient receptor potential cation channel, subfamily A, member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/26630/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/26630/55283_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
TSPO | Translocator protein (18kDa) | Cancer-related genes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins Transporters
| ![](/images/11232/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/11232/26243_B_7_7_rna_selected_60x60.jpg) | Expressed in all |
UGCG | UDP-glucose ceramide glucosyltransferase | Enzymes FDA approved drug targets Predicted membrane proteins Transporters
| ![](/images/24124/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/24124/ihc_cell_selected_60x60.jpg) | ![](/images/24124/53771_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
VAMP1 | Vesicle-associated membrane protein 1 (synaptobrevin 1) | FDA approved drug targets Mitochondrial proteins Predicted membrane proteins Transporters
| ![](/images/16119/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16119/35785_B_1_4_rna_selected_60x60.jpg) | Expressed in all |